Clinical Trial Update: Efficacy of Low-dose Venetoclax With Itraconazole + TACL for R/R ALL Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating low-dose venetoclax with itraconazole and TACL for relapsed/refractory acute lymphoblastic leukemia, with recruitment o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia

Drugs mentioned

• Itraconazole (Itraconazole)
• TACL
• Venetoclax (venetoclax)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Acute Lymphobkastic Leukemia, Acute Lymphoblastic Leukaemia Recurrent | Phase 2 | Status: RECRUITING